RS
Rajeev Sibal
About Rajeev Sibal
Data last updated:
Rajeev Sibal is a Director at Lupin Life Sciences Limited (since 2023), Director at Lupin Diagnostics Limited (since 2020) and Managing Director at Lupin Digital Health Limited (since 2021), and holds 1 more current directorship. The companies operate in Pharma, Healthcare and Internet. The 3 current companies with reported revenue have a combined latest revenue of ₹357 Cr; the largest is Lupin Life Sciences Limited at ₹257 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Jul 2023 | 2023 | ₹257 Cr (FY 2025) | Active | |
| Director | 15 Sep 2020 | 2011 | ₹98.57 Cr (FY 2025) | Active | |
| Managing Director | 21 May 2021 | 2021 | ₹1.94 Cr (FY 2025) | Active | |
| Director | 08 Mar 2025 | 2025 | Active |
Board colleagues of Rajeev Sibal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Manju Deshbandhu Gupta | 00209461 | Lupin Life Sciences Limited , Lupin Diagnostics Limited | Director |
| Nilesh Deshbandhu Gupta | 01734642 | Lupin Life Sciences Limited , Lupin Diagnostics Limited and 2 more | Director |
| Swaminathan Ramesh | 01833346 | Lupin Life Sciences Limited , Lupin Diagnostics Limited and 2 more | Director |
| Amit Kumar Gupta | Lupin Diagnostics Limited | Company Secretary | |
| Vishal Rathi | Lupin Diagnostics Limited | Cfo | |
| Hitanshu Chandresh Shah | Lupin Digital Health Limited | Cfo | |
| Juzer Yusuf Masta | Lupin Digital Health Limited | Company Secretary |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajeev Sibal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajeev Sibal
Rajeev Sibal currently holds 4 directorships: Lupin Life Sciences Limited (Director, since 17 Jul 2023, revenue ₹257 Cr (FY 2025)); Lupin Diagnostics Limited (Director, since 15 Sep 2020, revenue ₹98.57 Cr (FY 2025)); Lupin Digital Health Limited (Managing Director, since 21 May 2021, revenue ₹1.94 Cr (FY 2025)); Lupinlife Consumer Healthcare Limited (Director, since 08 Mar 2025).
Rajeev Sibal was first appointed on 15 Sep 2020 as Director at Lupin Diagnostics Limited. The most recent appointment on record is 08 Mar 2025 at Lupinlife Consumer Healthcare Limited.
The 3 current companies of Rajeev Sibal that report revenue have a combined latest revenue of ₹357 Cr: Lupin Life Sciences Limited ₹257 Cr (FY 2025); Lupin Diagnostics Limited ₹98.57 Cr (FY 2025); Lupin Digital Health Limited ₹1.94 Cr (FY 2025).
The current boards of Rajeev Sibal's companies include Manju Deshbandhu Gupta (Lupin Life Sciences Limited), Nilesh Deshbandhu Gupta (Lupin Life Sciences Limited), Swaminathan Ramesh (Lupin Life Sciences Limited), Amit Kumar Gupta (Lupin Diagnostics Limited), Vishal Rathi (Lupin Diagnostics Limited), Hitanshu Chandresh Shah (Lupin Digital Health Limited), among others.